Accumulus Synergy Spins Out Accumulus Technologies to Scale Proven Regulatory Platform and Accelerate Global Access to Therapies ...

Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ USA) to create simulations of cancer patient ...

With Annual NTM Case Rates Rising, Patients and Providers Are Urged to Recognize the Symptoms and Risks Experience the full interactive Multichannel News Release here: NTM lung disease is caused by ...